Prospects of RNA interference therapy for cancer

SI Pai, YY Lin, B Macaes, A Meneshian, CF Hung… - Gene therapy, 2006 - nature.com
RNA interference (RNAi) is a powerful gene-silencing process that holds great promise in
the field of cancer therapy. The discovery of RNAi has generated enthusiasm within the …

Amplified therapeutic targets in high-grade serous ovarian carcinoma–a review of the literature with quantitative appraisal

T Talbot, H Lu, EO Aboagye - Cancer Gene Therapy, 2023 - nature.com
High-grade serous ovarian carcinoma is a unique cancer characterised by universal TP53
mutations and widespread copy number alterations. These copy number alterations include …

Integrative Genomic Analysis of Phosphatidylinositol 3′-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer

L Zhang, J Huang, N Yang, J Greshock, S Liang… - Clinical Cancer …, 2007 - AACR
Abstract Purpose: The phosphatidylinositol 3′-kinase (PI3K) family plays a key regulatory
role in various cancer-associated signal transduction pathways. Here, we investigated the …

Integrative genomic analysis of protein kinase C (PKC) family identifies PKCι as a biomarker and potential oncogene in ovarian carcinoma

L Zhang, J Huang, N Yang, S Liang, A Barchetti… - Cancer research, 2006 - AACR
The protein kinase C (PKC) family plays a key regulatory role in a wide range of cellular
functions as well as in various cancer-associated signal transduction pathways. Here, we …

Hypoxia inducible factor 1-α regulates of platelet derived growth factor-B in human glioblastoma cells

D Yoshida, K Kim, M Noha, A Teramoto - Journal of neuro-oncology, 2006 - Springer
Hypoxia inducible factors (HIF) are transcription factors regulating expression of several
genes related to oxygen homeostasis in response to hypoxic stress. Although HIF1-α and …

Modulating the expression of disease genes with RNA-based therapy

M Wood, H Yin, G McClorey - PLoS genetics, 2007 - journals.plos.org
Conventional gene therapy has focused largely on gene replacement in target cells.
However, progress from basic research to the clinic has been slow for reasons relating …

Mutant PIK3CA-Bearing Colon Cancer Cells Display Increased Metastasis in an Orthotopic Model

XN Guo, A Rajput, R Rose, J Hauser, A Beko… - Cancer research, 2007 - AACR
Mutations in the PIK3CA gene are common in human cancers, including colon cancer. We
compared two pairs of colon cancer cells (HCT116 and DLD1) bearing only the wild-type …

Transcriptional Regulation of PIK3CA Oncogene by NF-κB in Ovarian Cancer Microenvironment

N Yang, J Huang, J Greshock, S Liang, A Barchetti… - PLoS …, 2008 - journals.plos.org
PIK3CA upregulation, amplification and mutation have been widely reported in ovarian
cancers and other tumors, which strongly suggests that PIK3CA is a promising therapeutic …

Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers

J Jeong, KS Kim, JS Moon, J Song, S Choi, K Kim… - Apoptosis, 2013 - Springer
Abstract The phosphatidylinositol 3-kinase (PI3K) pathway is one of the critical signaling
cascades playing important roles in the chemoresistance of human cancer cells, including …

Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities

A Bemmo, C Dias, AAN Rose, C Russo, P Siegel… - PloS one, 2010 - journals.plos.org
Background Breast cancer is the second most frequent type of cancer affecting women. We
are increasingly aware that changes in mRNA splicing are associated with various …